Connect with us

Hi, what are you looking for?

Jewish Business News

Bio-Tech

USAID funds African trial of pneumonia diagnosis device

Respimometer is envisioned as a lifesaving diagnostic tool for children in remote villages; and as a telemedicine tool in the developed world.

#BreathOfLife

respimometer-The prototype Respimometer. Photo courtesy of RespiDx

 

The US Agency for International Development (USAID) has granted $150, 000 to Jerusalem-based RespiDx to further refine its Respimometer for diagnosing childhood pneumonia in low-resource regions.

Respimometer is a cross between a pacifier and a digital oral thermometer, embedded with sensors to measure breathing as a way of detecting pneumonia on the spot. Pneumonia is a serious health problem among infants in the developing world.

The grant will cover manufacturing up to 200 Respimometers and performing a trial in the Democratic Republic of the Congo coordinated by Dr. Michael Hawkes of Alberta University (Canada) under the auspices of a local research NGO, the Association for Health Innovation in Africa.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

The grant follows the awarding of a Grand Challenges seed grant to RespiDx and a pilot trial of the prototype Respimometer during December 2015.

The test in Africa will identify cultural and field conditions that could impact the final design of the reusable product and the training protocol for healthcare workers, says Ian Solomon, VP business development for the Profile Group of Companies, RespiDx’s parent company.

“The idea is to simply diagnose and also simply treat children right in their villages, ” says Solomon.

 

 

In addition, Solomon says RespiDx is actively engaged in talking to HMOs and telemedicine companies in the United States, in order to adapt the product for their needs.

“We now envisage our RespiDx venture as having both pro-bono and for-profit arms, ” he tells ISRAEL21c. “The upcoming version of the product will measure not just temperature and respiratory rate but also all the vital signs except blood pressure.”

 

respidx

 

 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.